Study reveals why chemotherapy may be compromised in patients with pancreatic cancer

A study at The University of Texas MD Anderson Cancer Center may explain why chemotherapy drugs such as gemcitabine are not effective for many pancreatic cancer patients, and perhaps point to new approaches to treatment including enhancing  gemcitabine's ability to stop tumor growth.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news